Both in Pharmaceuticals
Karyopharm Therapeutics vs Propanc Biopharma
Over the past year KPTI returned −90.0% and PPCB returned −99.5%; their daily moves had a correlation of -0.01.
KPTI −90.0% PPCB −99.5%Growth of $1, one year, split-adjusted
| Metric | KPTI | PPCB |
|---|---|---|
| Price | $0.6106 | $1.80 |
| Market cap | $13.8M | $17.7M |
| Today | −30.60% | −14.69% |
| 1 month | −29.6% | −64.1% |
| 6 months | −93.0% | −93.0% |
| Year to date | −91.7% | −98.7% |
| 1 year | −90.0% | −99.5% |
| Revenue growth (YoY) | −11.9% | — |
| Gross margin | 96.8% | — |
| Net margin | −200.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.1× | — |
| Net cash | -$184.8M | $832.0K |
| Dividend yield | — | — |
| Volatility (60d) | 211.4% | 730.2% |
| Short % of float | 35.0% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).